Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,840
Total Claims
$716K
Drug Cost
371
Beneficiaries
$1,930
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+47%
Opioid rate vs peers
5.6% vs 3.8% avg
+64%
Cost per patient vs peers
$1,930 vs $1,174 avg
+39%
Brand preference vs peers
12.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
5.6%
Opioid Rate
493
Opioid Claims
$14K
Opioid Cost
12.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,081 claims · $551K
Generic: 7,684 claims · $162K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 71 | $83K |
| Apixaban | 144 | $67K |
| Rifaximin | 17 | $55K |
| Fluticasone/Umeclidin/Vilanter | 52 | $38K |
| Empagliflozin | 26 | $23K |
| Dapagliflozin Propanediol | 41 | $21K |
| Eslicarbazepine Acetate | 17 | $20K |
| Mirabegron | 66 | $19K |
| Semaglutide | 19 | $19K |
| Sitagliptin Phosphate | 22 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 59 | $14K |
| Sacubitril/Valsartan | 25 | $12K |
| Linaclotide | 21 | $12K |
| Linagliptin | 19 | $8,926 |
| Fluticasone/Vilanterol | 21 | $8,821 |
Prescribing Profile
Patient Profile
79
Avg Age
66%
Female
2.01
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data